Exelixis, Inc. (EXEL) Tops Q3 EPS by 4c, Reaffirms Guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $54.08 +0.73%
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Exelixis, Inc. (NASDAQ: EXEL) reported Q3 EPS of $0.60, $0.04 better than the analyst estimate of $0.56. Revenue for the quarter came in at $128.3 million versus the consensus estimate of $129.63 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Exelixis (EXEL) at Market Perform
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
